Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Noonan syndrome is a common genetic disorder that affects multiple parts of the body, characterized by distinctive facial features, short stature, and congenital heart defects. It is caused by mutations in genes involved in cell signaling pathways and occurs in approximately 1 in 1,000 to 1 in 2,500 live births. What is Noonan syndrome and how does it affect the body? Noonan syndrome is a multisystem genetic condition that can impact physical development and various organ functions.
1 people with Noonan Syndrome have shared their first-person experience on this question at DiseaseMaps.
TL;DR: Noonan syndrome is a common genetic disorder that affects multiple parts of the body, characterized by distinctive facial features, short stature, and congenital heart defects. It is caused by mutations in genes involved in cell signaling pathways and occurs in approximately 1 in 1,000 to 1 in 2,500 live births.
Noonan syndrome is a multisystem genetic condition that can impact physical development and various organ functions. While the clinical presentation is highly variable—meaning no two individuals with the condition are exactly alike—it most frequently involves the cardiovascular system, skeletal development, and growth patterns. Because the genes associated with Noonan syndrome control how cells grow and divide, the disorder can manifest in many different ways, ranging from mild learning disabilities and subtle physical traits to more complex medical needs requiring multidisciplinary care.
The clinical spectrum of Noonan syndrome is broad, but several common features are frequently observed by clinicians. At DiseaseMaps.org, 118 members have shared their experiences, highlighting the diversity of the condition. Common clinical findings include:
Noonan syndrome is caused by a change (mutation) in one of several genes that regulate the RAS/MAPK cell signaling pathway, which is essential for normal cell growth and differentiation. The most commonly affected gene is PTPN11, which is identified in about 50% of cases. The condition follows an autosomal dominant inheritance pattern, meaning a person only needs one copy of the mutated gene to have the condition. However, in many instances, Noonan syndrome occurs as a "de novo" or sporadic mutation, meaning the child is the first in the family to be affected and did not inherit the gene from a parent.
Noonan syndrome is often clinically referred to as a "RASopathy," a group of related conditions that share similar underlying genetic mechanisms. It is sometimes confused with Turner syndrome, particularly because both conditions can present with short stature and heart defects. However, Noonan syndrome affects both males and females equally, whereas Turner syndrome only affects females and involves a different chromosomal cause. Genetic testing is the gold standard for confirming the diagnosis and distinguishing it from other developmental disorders.
Medical disclaimer: This content is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.